Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Glenmark Pharmaceuticals discovers NADPH oxidase inhibitors

Nov. 28, 2018

Phase I results for PIN-201104 support progression to phase II for asthma

Nov. 27, 2018

Lung specificity means low tox for inhalable JAK inhibitor

Nov. 27, 2018

Theravance initiates phase I study of TD-8236 by inhalation for asthma

Nov. 26, 2018

Phase III study of VR-475 in severe uncontrolled asthma does not meet primary endpoint

Nov. 26, 2018

REALIST study explores use of mesenchymal stem cells to treat ARDS

Nov. 22, 2018

Phase I data on BLU-5937 support progression to phase II for chronic cough

Nov. 20, 2018

Phase III trial of STAGR-320 in house dust mite-induced allergic rhinitis meets primary endpoint

Nov. 20, 2018

Proteostasis Therapeutics patents mutant CFTR correctors

Nov. 19, 2018

Bridge Biotherapeutics files IND for BBT-877

Nov. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...